Skip to main content

Advertisement

Log in

Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events

  • Review
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

This study aims to compare different types of metabolic bariatric surgery (MBS) with lifestyle intervention/medical therapy (LSI/MT) for the treatment of overweight/obesity. The present and network meta-analysis (NMA) includes randomized trials. MBS was associated with a reduction of BMI, body weight, and percent weight loss, when compared to LSI/MT, and also with a significant reduction of HbA1c and a higher remission of diabetes. Meta-regression analyses revealed that BMI, a higher proportion of women, and a longer duration of trial were associated with greater effects of MBS. The NMA showed that all surgical procedures included (except greater curvature plication) were associated with a reduction of BMI. MBS is an effective option for the treatment of obesity. The choice of BMI thresholds for eligibility for surgery of patients with different complications should be performed making an evaluation of risks and benefits in each BMI category.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234. https://doi.org/10.1016/s0140-6736(23)01301-6 (In eng)

  2. Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26(1):28–35. https://doi.org/10.1093/ndt/gfq576. (In eng).

    Article  PubMed  Google Scholar 

  3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):854–65. (In eng).

  4. Rothberg AE, McEwen LN, Fraser T, Burant CF, Herman WH. The impact of a managed care obesity intervention on clinical outcomes and costs: a prospective observational study. Obesity (Silver Spring). 2013;21(11):2157–62. https://doi.org/10.1002/oby.20597. (In eng).

    Article  PubMed  Google Scholar 

  5. Wing RR, Reboussin D, Lewis CE. Intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(24):2358–9. https://doi.org/10.1056/NEJMc1312802. (In eng).

    Article  PubMed  Google Scholar 

  6. Pappachan JM, Viswanath AK. Medical management of diabesity: do we have realistic targets? Curr Diab Rep. 2017;17(1):4. https://doi.org/10.1007/s11892-017-0828-9. (In eng).

    Article  PubMed  Google Scholar 

  7. Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020;34(6):2332–58. https://doi.org/10.1007/s00464-020-07555-y. (In eng).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020;28(4):O1-o58. https://doi.org/10.1002/oby.22719. (In eng).

    Article  PubMed  Google Scholar 

  9. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33(1):3–14. https://doi.org/10.1007/s11695-022-06332-1. (In eng).

    Article  PubMed  Google Scholar 

  10. Garneau P, Glazer S, Jackson T, et al. Guidelines for Canadian bariatric surgical and medical centres: a statement from the Canadian Association of Bariatric Physicians and Surgeons. Can J Surg. 2022;65(2):E170-e177. https://doi.org/10.1503/cjs.020719. (In eng).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Smeets MJR, Liem RSL. No uniformity in the references of clinical practice guidelines for bariatric surgery: a review of 3 similar guidelines published in 2020. Obes Surg. 2021;31(12):5427–40. https://doi.org/10.1007/s11695-021-05746-7. (In eng).

    Article  PubMed  Google Scholar 

  12. De Luca M, Zappa MA, Zese M, et al. Development of the Italian clinical practice guidelines on bariatric and metabolic surgery: design and methodological aspects. Nutrients 2022;15(1). https://doi.org/10.3390/nu15010189 (In eng)

  13. Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol. 2013;66(2):158–72. https://doi.org/10.1016/j.jclinepi.2012.01.012. (In eng).

    Article  PubMed  Google Scholar 

  14. Kang JH, Le QA. Effectiveness of bariatric surgical procedures: a systematic review and network meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(46):e8632. https://doi.org/10.1097/md.0000000000008632. (In eng).

    Article  PubMed  Google Scholar 

  15. Wang L, Lin M, Yu J, et al. The impact of bariatric surgery versus non-surgical treatment on blood pressure: systematic review and meta-analysis. Obes Surg. 2021;31(11):4970–84. https://doi.org/10.1007/s11695-021-05671-9. (In eng).

    Article  PubMed  Google Scholar 

  16. Cosentino C, Marchetti C, Monami M, Mannucci E, Cresci B. Efficacy and effects of bariatric surgery in the treatment of obesity: network meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis NMCD. 2021;31(10):2815–24. https://doi.org/10.1016/j.numecd.2021.06.018. (In eng).

    Article  CAS  PubMed  Google Scholar 

  17. Cresci B, Cosentino C, Monami M, Mannucci E. Metabolic surgery for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2020;22(8):1378–87. https://doi.org/10.1111/dom.14045. (In eng).

    Article  CAS  PubMed  Google Scholar 

  18. Currie AC, Askari A, Fangueiro A, Mahawar K. Network meta-analysis of metabolic surgery procedures for the treatment of obesity and diabetes. Obes Surg. 2021;31(10):4528–41. https://doi.org/10.1007/s11695-021-05643-z. (In eng).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ding L, Fan Y, Li H, et al. Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials. Obes Rev. 2020;21(8):e13030. https://doi.org/10.1111/obr.13030. (In eng).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moher D, Liberati A, Tetzlaff J, Altman DGJAoim. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2009;151(4):264-269

  21. Association AD. 9. Cardiovascular disease and risk management: standards of medical care in diabetes—2018. Diabetes Care. 2017;41(Supplement_1):S86–104. https://doi.org/10.2337/dc18-S009.

    Article  Google Scholar 

  22. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928. (In eng).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195–203. https://doi.org/10.1097/xeb.0000000000000141. (In eng).

    Article  PubMed  Google Scholar 

  24. Cohen RV, Pereira TV, Aboud CM, et al. Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial. JAMA Surg. 2020;155(8):e200420. https://doi.org/10.1001/jamasurg.2020.0420.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3). https://doi.org/10.1001/jama.299.3.316

  26. Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59(5):945–53. https://doi.org/10.1007/s00125-016-3903-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. O’Brien PE, Brennan L, Laurie C, Brown W. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg. 2013;23(9):1345–53. https://doi.org/10.1007/s11695-013-0990-3.

    Article  PubMed  Google Scholar 

  28. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013;101(1):50–6. https://doi.org/10.1016/j.diabres.2013.04.005.

    Article  PubMed  Google Scholar 

  29. Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do not meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014;260(4):617–24. https://doi.org/10.1097/SLA.0000000000000919.

    Article  PubMed  Google Scholar 

  30. Simonson DC, Halperin F, Foster K, Vernon A, Goldfine AB. Clinical and patient-centered outcomes in obese patients with type 2 diabetes 3 years after randomization to Roux-en-Y gastric bypass surgery versus intensive lifestyle management: the SLIMM-T2D study. Diabetes Care. 2018;41(4):670–9. https://doi.org/10.2337/dc17-0487.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle Intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A 1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA. 2018;319(3):266. https://doi.org/10.1001/jama.2017.20813.

    Article  PubMed  PubMed Central  Google Scholar 

  32. MacLaughlin HL, Hall WL, Patel AG, et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3–4 CKD: a randomized controlled pilot study. Am J Kidney Dis. 2014;64(4):660–3. https://doi.org/10.1053/j.ajkd.2014.06.011.

    Article  PubMed  Google Scholar 

  33. Cheng A, Yeoh E, Moh A, et al. Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m2: a 5-year randomized controlled trial. Diabetes Res Clin Pract. 2022;188:109900. https://doi.org/10.1016/j.diabres.2022.109900.

    Article  PubMed  Google Scholar 

  34. Spaggiari M, Di Cocco P, Tulla K, et al. Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. Am J Transplant. 2021;21(4):1525–34. https://doi.org/10.1111/ajt.16322.

    Article  CAS  PubMed  Google Scholar 

  35. Feigel-Guiller B, Drui D, Dimet J, et al. Laparoscopic gastric banding in obese patients with sleep apnea: a 3-year controlled study and follow-up after 10 years. Obes Surg. 2015;25(10):1886–92. https://doi.org/10.1007/s11695-015-1627-5.

    Article  PubMed  Google Scholar 

  36. Dowsey MM, Brown WA, Cochrane A, Burton PR, Liew D, Choong PF. Effect of bariatric surgery on risk of complications after total knee arthroplasty: a randomized clinical trial. JAMA Netw Open. 2022;5(4):e226722. https://doi.org/10.1001/jamanetworkopen.2022.6722.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mollan SP, Mitchell JL, Ottridge RS, et al. Effectiveness of Bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol. 2021;78(6):678. https://doi.org/10.1001/jamaneurol.2021.0659.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Petry TZ, Fabbrini E, Otoch JP, et al. Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial: duodenal-jejunal bypass surgery and diabetes. Obesity. 2015;23(10):1973–9. https://doi.org/10.1002/oby.21190.

    Article  CAS  PubMed  Google Scholar 

  39. Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137(11):1132–42. https://doi.org/10.1161/CIRCULATIONAHA.117.032130.

    Article  PubMed  Google Scholar 

  40. Xiang AH, Trigo E, Martinez M, et al. Impact of gastric banding versus metformin on β-cell function in adults with impaired glucose tolerance or mild type 2 diabetes. Diabetes Care. 2018;41(12):2544–51. https://doi.org/10.2337/dc18-1662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Dixon JB, Schachter LM, O’Brien PE, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308(11):1142. https://doi.org/10.1001/2012.jama.1158042.

    Article  CAS  PubMed  Google Scholar 

  42. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73. https://doi.org/10.1016/S0140-6736(15)00075-6.

    Article  PubMed  Google Scholar 

  43. Courcoulas AP, Gallagher JW, Neiberg RH, et al. Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-year outcomes from a randomized trial. J Clin Endocrinol Metab. 2020;105(3):866–76. https://doi.org/10.1210/clinem/dgaa006.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376(7):641–51. https://doi.org/10.1056/NEJMoa1600869.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Eskandaros MS, Abbass A, Zaid MH, Darwish AA. Laparoscopic one anastomosis gastric bypass versus laparoscopic Roux-en-Y gastric bypass effects on pre-existing mild-to-moderate gastroesophageal reflux disease in patients with obesity: a randomized controlled study. Obes Surg. 2021;31(11):4673–81. https://doi.org/10.1007/s11695-021-05667-5.

    Article  PubMed  Google Scholar 

  46. Biter LU, Leeman M, Friskes I, et al. The prognostic value of the Dutch sweet eating questionnaire on weight loss after metabolic surgery: a randomized controlled trial. Obes Surg. 2020;30(7):2497–504. https://doi.org/10.1007/s11695-020-04527-y.

    Article  CAS  PubMed  Google Scholar 

  47. Casajoana A, Pujol J, Garcia A, et al. Predictive value of gut peptides in T2D remission: randomized controlled trial comparing metabolic gastric bypass, sleeve gastrectomy and greater curvature plication. Obes Surg. 2017;27(9):2235–45. https://doi.org/10.1007/s11695-017-2669-7.

    Article  PubMed  Google Scholar 

  48. Risstad H, Svanevik M, Kristinsson JA, et al. Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60: a double-blind, randomized clinical trial. JAMA Surg. 2016;151(12):1146. https://doi.org/10.1001/jamasurg.2016.2798.

    Article  PubMed  Google Scholar 

  49. Catheline JM, Fysekidis M, Bendacha Y, et al. Prospective, multicentric, comparative study between sleeve gastrectomy and Roux-en-Y gastric bypass, 277 patients, 3 years follow-up. J Visc Surg. 2019;156(6):497–506. https://doi.org/10.1016/j.jviscsurg.2019.04.013.

    Article  PubMed  Google Scholar 

  50. Grubnik VV, Ospanov OB, Namaeva KA, Medvedev OV, Kresyun MS. Randomized controlled trial comparing laparoscopic greater curvature plication versus laparoscopic sleeve gastrectomy. Surg Endosc. 2016;30(6):2186–91. https://doi.org/10.1007/s00464-015-4373-9.

    Article  CAS  PubMed  Google Scholar 

  51. Darabi S, Talebpour M, Zeinoddini A, Heidari R. Laparoscopic gastric plication versus mini-gastric bypass surgery in the treatment of morbid obesity: a randomized clinical trial. Surg Obes Relat Dis. 2013;9(6):914–9. https://doi.org/10.1016/j.soard.2013.07.012.

    Article  PubMed  Google Scholar 

  52. Hedberg J, Sundbom M. Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass—a randomized controlled trial. Surg Obes Relat Dis. 2012;8(3):338–43. https://doi.org/10.1016/j.soard.2012.01.014.

    Article  PubMed  Google Scholar 

  53. Hall JC, Watts JMcK, Oʼbrien PE, et al. Gastric surgery for morbid obesity: the Adelaide study. Ann Surg. 1990;211(4):419–27. https://doi.org/10.1097/00000658-199004000-00007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hofsø D, Fatima F, Borgeraas H, et al. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(12):912–24. https://doi.org/10.1016/S2213-8587(19)30344-4.

    Article  PubMed  Google Scholar 

  55. Horbach T, Meyer G, Morales-Conde S, et al. Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study. Int J Obes. 2016;40(12):1891–8. https://doi.org/10.1038/ijo.2016.159.

    Article  CAS  Google Scholar 

  56. Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248–56. https://doi.org/10.1002/bjs.10400.

    Article  CAS  PubMed  Google Scholar 

  57. Jain M, Tantia O, Goyal G, et al. LSG vs MGB-OAGB: 5-year follow-up data and comparative outcome of the two procedures over long term—results of a randomised control trial. Obes Surg. 2021;31(3):1223–32. https://doi.org/10.1007/s11695-020-05119-6.

    Article  PubMed  Google Scholar 

  58. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite Suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7. https://doi.org/10.1097/SLA.0b013e318156f012.

    Article  PubMed  Google Scholar 

  59. Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg. 2011;21(11):1650–6. https://doi.org/10.1007/s11695-011-0479-x.

    Article  PubMed  Google Scholar 

  60. Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia. 2013;56(9):1914–8. https://doi.org/10.1007/s00125-013-2965-2.

    Article  PubMed  Google Scholar 

  61. Paluszkiewicz R, Kalinowski P, Wróblewski T, et al. Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. wiitm. 2012;4:225–32. https://doi.org/10.5114/wiitm.2012.32384.

    Article  Google Scholar 

  62. de Medeiros VG, Pajecki D, Dias MCG, Dantas ACB, de Cleva R, Santo MA. Food tolerance and nutritional risk after sleeve gastrectomy and Roux-en-Y gastric bypass in elderly patients with severe obesity: a prospective, randomized controlled trial. Arq Gastroenterol. 2022;59(3):370–4. https://doi.org/10.1590/s0004-2803.202203000-67.

    Article  PubMed  Google Scholar 

  63. Nguyen NT, Slone JA, Nguyen XMT, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250(4):631–41. https://doi.org/10.1097/SLA.0b013e3181b92480.

    Article  PubMed  Google Scholar 

  64. Praveen Raj P, Kumaravel R, Chandramaliteeswaran C, Rajpandian S, Palanivelu C. Is Laparoscopic duodenojejunal bypass with sleeve an effective alternative to Roux en Y gastric bypass in morbidly obese patients: preliminary results of a randomized trial. Obes Surg. 2012;22(3):422–6. https://doi.org/10.1007/s11695-011-0507-x.

    Article  CAS  PubMed  Google Scholar 

  65. Olbers T, Fagevik-Olsén M, Maleckas A, Lönroth H. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg. 2005;92(5):557–62. https://doi.org/10.1002/bjs.4974.

    Article  CAS  PubMed  Google Scholar 

  66. Talebpour M, Sadid D, Talebpour A, Sharifi A, Davari FV. Comparison of short-term effectiveness and postoperative complications: laparoscopic gastric plication vs laparoscopic sleeve gastrectomy. Obes Surg. 2018;28(4):996–1001. https://doi.org/10.1007/s11695-017-2951-8.

    Article  PubMed  Google Scholar 

  67. Roushdy A, Abdel-Razik MA, Emile SH, et al. Fasting ghrelin and postprandial GLP-1 levels in patients with morbid obesity and medical comorbidities after sleeve gastrectomy and one-anastomosis gastric bypass: a randomized clinical trial. Surg Laparosc Endosc Percutaneous Tech. 2021;31(1):28–35. https://doi.org/10.1097/SLE.0000000000000844.

    Article  Google Scholar 

  68. Skroubis G, Anesidis S, Kehagias I, Mead N, Vagenas K, Kalfarentzos F. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg. 2006;16(4):488–95. https://doi.org/10.1381/096089206776327251.

    Article  PubMed  Google Scholar 

  69. Skroubis G, Kouri N, Mead N, Kalfarentzos F. Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35–50 kg/m2). Obes Surg. 2014;24(2):197–204. https://doi.org/10.1007/s11695-013-1081-1.

    Article  PubMed  Google Scholar 

  70. Wallenius V, Dirinck E, Fändriks L, Maleckas A, le Roux CW, Thorell A. Glycemic control after sleeve gastrectomy and Roux-En-Y gastric bypass in obese subjects with type 2 diabetes mellitus. Obes Surg. 2018;28(6):1461–72. https://doi.org/10.1007/s11695-017-3061-3.

    Article  PubMed  Google Scholar 

  71. Peterli R, Borbély Y, Kern B, et al. Early results of the Swiss multicentre bypass or sleeve study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690–5. https://doi.org/10.1097/SLA.0b013e3182a67426.

    Article  PubMed  Google Scholar 

  72. Musella M, Vitiello A, Berardi G, Velotti N, Pesce M, Sarnelli G. Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial. Surg Endosc. 2021;35(12):6777–85. https://doi.org/10.1007/s00464-020-08182-3.

    Article  PubMed  Google Scholar 

  73. Werling M, Fändriks L, Björklund P, et al. Long-term results of a randomized clinical trial comparing Roux-en-Y gastric bypass with vertical banded gastroplasty. Br J Surg. 2012;100(2):222–30. https://doi.org/10.1002/bjs.8975.

    Article  PubMed  Google Scholar 

  74. Scozzari G, Farinella E, Bonnet G, Toppino M, Morino M. Laparoscopic adjustable silicone gastric banding vs laparoscopic vertical banded gastroplasty in morbidly obese patients: long-term results of a prospective randomized controlled clinical trial. Obes Surg. 2009;19(8):1108–15. https://doi.org/10.1007/s11695-009-9871-1.

    Article  PubMed  Google Scholar 

  75. Nilsell, Anders Thoörne, Sv K. Prospective randomised comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg. 2001;167(7):504–509. https://doi.org/10.1080/110241501316914876

  76. Lundell L, Ruth M, Olbe L. Vertical banded gastroplasty or gastric banding for morbid obesity: effects on gastro-oesophageal reflux. Eur J Surg. 1997;163(7):525–31.

    CAS  PubMed  Google Scholar 

  77. Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241. https://doi.org/10.1001/jama.2017.20313.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Cortez RV, Petry T, Caravatto P, et al. Shifts in intestinal microbiota after duodenal exclusion favor glycemic control and weight loss: a randomized controlled trial. Surg Obes Relat Dis. 2018;14(11):1748–54. https://doi.org/10.1016/j.soard.2018.07.021.

    Article  PubMed  Google Scholar 

  79. Tang Q, Sun Z, Zhang N, et al. Cost-effectiveness of bariatric surgery for type 2 diabetes mellitus: a randomized controlled trial in China. Medicine. 2016;95(20):e3522. https://doi.org/10.1097/MD.0000000000003522.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Yang J, Wang C, Cao G, et al. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28–35 kg/m2. BMC Surg. 2015;15(1):88. https://doi.org/10.1186/s12893-015-0074-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Zhang Y, Zhao H, Cao Z, et al. A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg. 2014;24(10):1617–24. https://doi.org/10.1007/s11695-014-1258-2.

    Article  PubMed  Google Scholar 

  82. Murphy R, Clarke MG, Evennett NJ, et al. Laparoscopic sleeve gastrectomy versus banded Roux-en-Y gastric bypass for diabetes and obesity: a prospective randomised double-blind trial. Obes Surg. 2018;28(2):293–302. https://doi.org/10.1007/s11695-017-2872-6.

    Article  PubMed  Google Scholar 

  83. Morino M, Toppino M, Bonnet G, del Genio G. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg. 2003;238(6):835–42. https://doi.org/10.1097/01.sla.0000098627.18574.72.

    Article  PubMed  PubMed Central  Google Scholar 

  84. MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg. 1993;165(1):155–62. https://doi.org/10.1016/S0002-9610(05)80420-9.

    Article  CAS  PubMed  Google Scholar 

  85. Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309. https://doi.org/10.1016/S0140-6736(19)30475-1.

    Article  PubMed  Google Scholar 

  86. Lee YM, Low HC, Lim LG, et al. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. Gastrointest Endosc. 2012;76(4):756–60. https://doi.org/10.1016/j.gie.2012.05.023.

    Article  PubMed  Google Scholar 

  87. Lee WJ, Chong K, Lin YH, Wei JH, Chen SC. Laparoscopic sleeve gastrectomy versus single anastomosis (Mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24(9):1552–62. https://doi.org/10.1007/s11695-014-1344-5.

    Article  PubMed  Google Scholar 

  88. Level L, Rojas A, Piñango S, Avariano Y. One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial. Langenbecks Arch Surg. 2021;406(1):171–9. https://doi.org/10.1007/s00423-020-01949-1.

    Article  PubMed  Google Scholar 

  89. Thompson MJ, Clinger BN, Simonds RM, Hochheimer CJ, Lahaye LA, Golladay GJ. Probability of undiagnosed obstructive sleep apnea does not correlate with adverse pulmonary events nor length of stay in hip and knee arthroplasty using intrathecal opioid. J Arthroplasty. 2017;32(9):2676–9. https://doi.org/10.1016/j.arth.2017.02.043.

    Article  PubMed  Google Scholar 

  90. Coretti S, Ruggeri M, McNamee P. The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res. 2014;14(2):221–33. https://doi.org/10.1586/14737167.2014.894462.

    Article  PubMed  Google Scholar 

  91. Kolotkin RL, Crosby RD, Williams GR, Hartley GG, Nicol S. The relationship between health-related quality of life and weight loss. Obes Res. 2001;9(9):564–71. https://doi.org/10.1038/oby.2001.73.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Matteo Monami and Edoardo Mannucci were involved in each of the following points: (1) design, (2) data collection, (3) analysis, (4) writing the manuscript. Maurizio De Luca, Monica Zese, Giovanni Antonio Silverii, Benedetta Ragghianti, Giulia Bandini, Pietro Forestieri, Marco Antonio Zappa, Giuseppe Navarra, Diego Foschi, Mario Musella, Giuliano Sarro, Vincenzo Pilone, Enrico Facchiano, Mirto Foletto, Stefano Olmi, Marco Raffelli, Rosario Bellini, Paolo Gentileschi, Maria Rosaria Cerbone, Ilenia Grandone, Giovanna Berardi, Nicola Di Lorenzo, Marcello Lucchese, Luigi Piazza, Giovanni Casella, Emilio Manno, Alberto Zaccaroni, Alessandro Balani were involved in each of the following points: (1) data collection, (2) manuscript revision. All the authors approved the final version of this manuscript. Dr. Matteo Monami is the person who takes full responsibility for the work as a whole, including the study design, access to data, and the decision to submit and publish the manuscript.

Corresponding author

Correspondence to Monica Zese.

Ethics declarations

Ethical Approval

Not applicable.

Competing Interests

Matteo Monami has received speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Bristol Myers Squibb. Edoardo Mannucci has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Merck, Novartis, and Takeda. Maurizio De Luca, Monica Zese, Giovanni Antonio Silverii, Benedetta Ragghianti, Giulia Bandini, Pietro Forestieri, Marco Antonio Zappa, Giuseppe Navarra, Diego Foschi, Mario Musella, Giuliano Sarro, Vincenzo Pilone, Enrico Facchiano, Mirto Foletto, Stefano Olmi, Marco Raffelli, Rosario Bellini, Paolo Gentileschi, Maria Rosaria Cerbone, Ilenia Grandone, Giovanna Berardi, Nicola Di Lorenzo, Marcello Lucchese, Luigi Piazza, Giovanni Casella, Emilio Manno, Alberto Zaccaroni, Alessandro Balani has no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 2831 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Luca, M., Zese, M., Silverii, G.A. et al. Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events. OBES SURG 33, 4147–4158 (2023). https://doi.org/10.1007/s11695-023-06909-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-023-06909-4

Keywords

Navigation